Document Type

Article

Publication Date

2-3-2023

Abstract

This report describes the methods and preliminary results for the manuscript titled, “Spending on Phased Clinical Development of Approved Drugs by the US National Institutes of Health Compared With Industry.”

DOI

https://doi.org/10.5281/zenodo.7603331

Share

COinS